Abstract: Applicants have successfully generated heritable phenotypes in plants making them resistant to bacterial blight. TAL effector binding elements, (EBEs) of bacterial pathogen disease susceptibility genes are modified to prevent induction of expression associated with disease states caused by the bacterial pathogens. Surprisingly, Applicants have found that modifications may be made in the EBEs of these genes which prevent bacterial pathogen induction, but still allow for normal plant development and seed production. Nucleic acid sequences for generating such plants, amino acid sequences, cells, vectors and expression constructs are included as well as resistant plants, seeds and lines.
Type:
Grant
Filed:
December 27, 2012
Date of Patent:
June 27, 2017
Assignee:
Iowa State University Research Foundation, Inc.
Abstract: In some embodiments, a wastewater treatment system may reduce contaminants in water. A system may include one or more bioreactors which include a substrate that supports a biofilm. The bacteria used to form the biofilm may be selected to maximize the reduction of contaminants in water. Various components of the wastewater treatment system may be optimized to improve the efficiency and energy consumption of the wastewater system.
Type:
Grant
Filed:
October 31, 2014
Date of Patent:
June 27, 2017
Assignee:
Sam Houston State University
Inventors:
R. Gavin Jones, Kenneth Wilson, Sabin Holland, Michael D. Rainone
Abstract: A method, a computer readable medium and an apparatus for optimizing a cellular network architecture are disclosed. For example, the method obtains network traffic data for a plurality of different endpoint device types, wherein the network traffic data comprises network traffic data for each of the plurality of different endpoint device types, and predicts a future traffic pattern for one of the plurality of different endpoint device types based on the network traffic data. The method then adjusts a parameter of the cellular network architecture in response to the future traffic pattern predicted for the one of the plurality of different endpoint device types.
Type:
Grant
Filed:
June 15, 2015
Date of Patent:
June 27, 2017
Assignees:
AT&T Intellectual Property I, L.P., Board of Trustees of Michigan State University
Inventors:
Jia Wang, Lusheng Ji, Xiang-Yang Alexander Liu, Muhammad Zubair Shafiq
Abstract: The present invention relates to compositions for and methods of optically imaging tissues or cells using imaging agents having desirable in vivo properties that result in improved signal-to-background ratio.
Type:
Grant
Filed:
April 7, 2015
Date of Patent:
June 27, 2017
Assignees:
Beth Israel Deaconess Medical Center, Inc., Georgia State University Research Foundation Inc.
Abstract: A method for controlling conidial germination and mycelial growth in fungi comprising contacting a fungal cell with anti-fungal small molecules in an amount effective to reduce or inhibit conidial germination and mycelial growth. A method for controlling bark beetle infestations of pine trees comprising contacting one or more fungal cells with anti-fungal small molecules in an amount effective to reduce or inhibit conidial germination and mycelial growth. The anti-fungal small molecules are 5-(p-Bromobenzylidine)-?-isopropyl-4-oxo-2-thioxo-3-thiozolidineacetic acid, 2-[5-(4-chlorobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-3-methylbutanoic acid, 2-[5-(4-hydroxybenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]pentanoic acid, [5-(4-isopropylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid or 2-[5-(2-chlorobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]pentanoic acid.
Type:
Grant
Filed:
July 12, 2016
Date of Patent:
June 27, 2017
Assignee:
Montana State University—Billings
Inventors:
Kurt A. Toenjes, David K. Butler, Joy Goffena
Abstract: A configurable ME MTJ XOR/XNOR gate includes an insulator separating a top and bottom FM layer, a top ME layer with a first boundary magnetism at an interface of the top ME layer and the top FM layer, a bottom ME layer with a second boundary magnetism at an interface of the bottom ME layer and the bottom FM layer, and a top electrode coupled to the top ME layer and a bottom electrode coupled to the bottom ME layer. A voltage between the top electrode and FM layer is a first input, a voltage between the bottom electrode and FM layer is a second input, and a resistance between the top and bottom FM layer is indicative of the XOR or the XNOR of the inputs. The configurable ME MTJ XOR/XNOR gate has reduced energy consumption, smaller area, faster switching times, is non-volatile, and is configurable.
Type:
Grant
Filed:
October 28, 2016
Date of Patent:
June 27, 2017
Assignees:
The Research Foundation for the State University of New York, Board of Regents, the University of Texas System
Abstract: A direct-write lithography apparatus includes a polarization selector stage configured to vary a polarization orientation angle of light from a light source, a focusing element configured to focus the light from the light source into a spot at a focal plane thereof, and a scanning stage configured to scan the spot in at least two dimensions along a surface of a polarization-sensitive recording medium that is arranged proximate to the focal plane such that neighboring scans substantially overlap. The polarization selector stage and the scanning stage are configured to be operated independently of one another. Related fabrication methods of and optical elements fabricated thereby are also discussed.
Type:
Grant
Filed:
October 15, 2013
Date of Patent:
June 27, 2017
Assignee:
North Carolina State University
Inventors:
Michael J. Escuti, Matthew N. Miskiewicz, Jihwan Kim
Abstract: Methods for making and using a programmable bead composition that in some embodiments includes a magnetic bead coupled to an antibody with DMTMM and an antigen coupled to the antibody, with the antigen having been expressed from a human cell lysate (FIG. 1). An ELISA method with the composition includes contacting a fluid sample from a patient with the magnetic programmable bead composition, the composition comprising a plurality of magnetic beads coupled to an antibody with MM and being bound to an antigen expressed from a human call lysate, and adding a detection antibody under conditions and for a time to measure the detection antibody.
Type:
Application
Filed:
March 18, 2015
Publication date:
June 22, 2017
Applicant:
Arizona Board of Regents on behalf of Arizona State University
Inventors:
Karen ANDERSON, Julia CHENG, Joshua LABAER
Abstract: Pneumonia due to the fungus Pneumocystis jirovecii is a life-threatening infection that occurs in immunocompromised patients. The inability to culture the organism as well as the lack of a sequenced genome has hindered antigen discovery that could be useful in developing effective vaccines, therapeutic antibodies and diagnostic methods. A method of surface proteomics of Pneumocystis murina that reliably detects surface proteins that are conserved in Pneumocystis jirovecii is described. In particular, eight identified P. murina surface proteins are described. Methods of eliciting immune responses against the identified proteins, generating therapeutic antibodies against the identified proteins, as well as diagnostic methods based on the identified peptides are described.
Type:
Application
Filed:
March 19, 2015
Publication date:
June 22, 2017
Applicants:
University of Pittsburgh - Of the Commonwealth System of Higher Education, University of New Orleans, Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Inventors:
Jay Kennedy Kolls, Mingquan Michael Zheng, Yang Cai, Taylor John Eddens, David M. Ricks
Abstract: A reaction product of: (a)) at least one cinnamyl alcohol or ester of cinnamic acid; (b) at least one unsaturated polyester resin, at least one vinyl ester resin, or a mixture of an unsaturated polyester resin and a vinyl ester resin; (c) at least one (meth)acrylated vegetable oil; and (d) a free radical initiator system.
Abstract: Various embodiments of contaminant removal systems, compositions, and methods are described herein. In one embodiment, a method for oxidizing a contaminant includes contacting the contaminant with a peroxygen compound and initializing, maintaining, or propagating degradation of the peroxygen compound with an oxygenated organic compound, thereby releasing oxidizing radicals. The method also includes oxidizing the contaminant with the released oxidizing radicals.
Abstract: A carbon dioxide adsorbent including a hierarchical zeolite. The hierarchical zeolite defines micropores having a pore width between about 0.4 nm and about 2 nm, and at least one of: mesopores having a pore width between about 2 nm and about 50 nm; and macropores having a pore width greater than about 50 nm.
Type:
Application
Filed:
June 12, 2015
Publication date:
June 22, 2017
Applicant:
Arizona Board of Regents on behalf of Arizona State University
Abstract: The present disclosure is directed to adeno-associated viral vector monoclonal antibody constructs and compositions thereof, methods of improving locomotor function after spinal cord injury, methods of treating neurodegenerative diseases.
Type:
Application
Filed:
March 3, 2017
Publication date:
June 22, 2017
Applicant:
The Research Foundation for The State University of New York
Abstract: A tunable superomniphobic surface with flower-like TiO2 nanostructures was fabricated into a device with precisely tailored surface energy domains that can sort droplets by surface tension. This apparatus and method for droplet sorting will enable inexpensive and energy-efficient analytical devices for personalized point-of-care diagnostic platforms, lab-on-a-chip systems, fuel sensor applications, biochemical assays and biosensors.
Type:
Application
Filed:
February 27, 2017
Publication date:
June 22, 2017
Applicant:
Colorado State University Research Foundation
Inventors:
Arun K. KOTA, Sanli MOVAFAGHI, Shantanu JATHAR
Abstract: A vaccine is disclosed that promotes CD4+ T cell-independent host defense mechanisms to defend against infection by fungi such as Pneumocystis spp. The vaccine may be used to prevent or to treat fimgal infections. The novel vaccine can provide protective immunity, even for immunocompromised individuals such as HIV patients having reduced levels of CD4+ T cells.
Type:
Application
Filed:
February 27, 2017
Publication date:
June 22, 2017
Applicants:
University of Pittsburgh - of the Commonwealth System of Higher Education, Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
Inventors:
JAY K. KOLLS, Michael Zheng, Karen Norris, Heather Kling
Abstract: A cancer chemotherapeutic agent that is particularly kinase suppressing and/or any other signaling pathway interfering agents and pharmaceutical formulations/compositions involving the same and its process of manufacture is provided. A potential the cancer chemotherapeutic agent is provided which apart from stated anticancer activity as a proven kinase suppressing and/or any other signaling pathway interfering agent could also involve specific potential binding affinity towards the intramolecular G-Quadruplex DNA structure and/or other potential quadruplex forming sequences over duplex DNA structures favors further diverse end use and application including but not limited to antiaging, antiangiogenic, antiproliferative, antitumor, antibiotic, antiviral, antifungal and multiple anticancer therapeutics, and also possesses favorable cytotoxicity values towards uncontrollably proliferative cells by inducing apoptosis irrespective of cells' p53 status, without being cytotoxic to normal cells.
Type:
Grant
Filed:
September 27, 2013
Date of Patent:
June 20, 2017
Assignees:
Bose Institute, West Bengal State University
Abstract: The invention relates to a polypeptide of a protective antigenic determinant (PAD polypeptide) of porcine reproductive and respiratory syndrome virus (PRRSV) and nucleic acids encoding a PAD polypeptide. The PAD polypeptide and nucleic acids encoding a PAD polypeptide are useful in the development of antibodies directed to PAD, vaccines effective in providing protection against PRRSV infection, and diagnostic assays detecting the presence of PAD antibodies generated by a PAD-specific vaccine. The invention also discloses methods of generating antibodies to PAD, for vaccinating a pig to provide protection from PRRSV infections, a method of preparing the vaccine, a method of treating PRRSV infections in a pig, and a method of detecting antibodies to PAD of PRRSV.
Type:
Grant
Filed:
May 15, 2014
Date of Patent:
June 20, 2017
Assignee:
Iowa State University Research Foundation, Inc.
Abstract: Systems, methods, and media for detecting an anatomical object in a medical device image are provided. In some embodiments, system for detecting an anatomical object in a medical device image are provided, the systems comprising: at least one hardware processor that: applies the medical device image to a classifier having a plurality of stages, wherein a first stage of the plurality of stages and a second stage of the plurality of stages each includes a strong learner formed from a plurality of weak learners, and the weak learners in the second stage include a plurality of the weak learners included in the first stage; and identifies the medical device image as being positive or negative of showing the anatomical object based on the application the medical device image to be classifier.
Type:
Grant
Filed:
February 13, 2012
Date of Patent:
June 20, 2017
Assignee:
Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behalf of Arizona State University
Abstract: A novel bio-based superabsorbent polymer material based on a proteinaceous natural polymer is introduced herein. There is further disclosed a method for the manufacture of such a bio-based crosslinked superabsorbent polymer material. The method includes, but not limited to, introducing polymerizable unsaturated groups onto the natural polymer or its derivative so as to yield a macromonomer. The macromonomer can be formed by covalently binding unsaturated carbon-carbon double bonds to a proteinaceous substrate through a reaction of a selected chemical compound and the amino group on the proteinaceous substrate. The macromonomer is then copolymerized with unsaturated co-monomer(s) to form a crosslinked superabsorbent material.